Cidara Therapeutics (CDTX) Stock Chart & Stock Price History → The AI stock to buy right now (From StockEarnings) (Ad) Free CDTX Stock Alerts $12.68 +0.87 (+7.37%) (As of 05/2/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Cidara Therapeutics Stock Price Performance5 Day Performance+0.40%1 Month Performance-40.75%3 Month Performance-9.30%6 Month Performance-26.68%Year-To-Date Performance-20.15%1 Year Performance-37.84% Receive CDTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… CDTX Stock Chart for Friday, May, 3, 2024 CDTX Chart by TradingView Cidara Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2024$11.81$12.68+7.37%$12.85$11.5263,620 shs$57.82 million05/01/2024$11.98$11.81-1.42%$11.86$11.02107,662 shs$53.85 million04/30/2024$12.33$11.98-2.80%$12.64$11.7274,157 shs$54.63 million04/29/2024$12.63$12.33-2.41%$12.81$11.90112,384 shs$56.20 million04/26/2024$13.00$12.63-2.85%$13.43$11.57199,445 shs$57.59 million04/25/2024$12.29$13.00+5.78%$14.96$12.13751,351 shs$1.19 billion Get the Latest News and Ratings for CDTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/24/2024$10.25$12.29+19.90%$12.59$10.11169,313 shs$1.11 billion04/23/2024$10.28$10.25-0.27%$11.60$10.0093,209 shs$46.44 million04/22/2024$13.62$10.28-24.54%$12.96$10.00187,802 shs$46.57 million04/19/2024$14.44$13.62-5.68%$14.80$13.6017,614 shs$61.71 million04/18/2024$14.44$14.44-0.03%$15.00$14.3013,660 shs$65.43 million04/17/2024$14.60$14.44-1.07%$16.00$14.2021,292 shs$65.45 million04/16/2024$16.49$14.60-11.48%$17.40$13.8062,826 shs$66.15 million04/15/2024$16.20$16.49+1.81%$17.60$16.4015,238 shs$74.73 million04/12/2024$17.28$16.20-6.26%$17.82$15.7726,882 shs$73.40 million04/11/2024$18.40$17.28-6.09%$19.20$16.5026,244 shs$78.30 million04/10/2024$17.50$18.40+5.15%$19.55$15.6045,681 shs$83.38 million04/09/2024$21.40$17.50-18.22%$22.00$17.3083,638 shs$79.29 million04/08/2024$23.20$21.40-7.76%$24.00$20.8069,920 shs$96.96 million04/05/2024$21.60$23.20+7.41%$24.20$20.00113,732 shs$105.12 million04/04/2024$21.00$21.60+2.86%$23.00$20.4042,680 shs$97.87 million04/03/2024$21.40$21.00-1.87%$24.40$20.80131,697 shs$95.15 million04/02/2024$19.36$21.40+10.56%$21.80$18.6471,120 shs$96.96 million04/01/2024$18.40$19.36+5.20%$20.00$15.6187,176 shs$87.70 million03/29/2024$18.40$18.40$19.17$17.0075,452 shs$83.37 million03/28/2024$16.84$18.40+9.25%$19.17$17.2075,409 shs$83.37 million03/27/2024$14.80$16.84+13.80%$17.00$14.8072,061 shs$76.31 million03/26/2024$14.93$14.80-0.86%$15.00$14.4023,072 shs$67.06 million03/25/2024$15.55$14.93-3.98%$15.90$14.4224,967 shs$67.64 million03/22/2024$16.06$15.55-3.21%$16.37$15.2033,485 shs$70.44 million03/21/2024$15.26$16.06+5.24%$16.40$15.6036,944 shs$72.78 million03/20/2024$14.28$15.26+6.85%$15.55$14.3343,926 shs$69.15 million03/19/2024$13.87$14.28+2.98%$14.88$13.6432,766 shs$64.72 million03/18/2024$13.70$13.87+1.26%$14.60$13.7130,899 shs$62.85 million03/15/2024$12.82$13.70+6.85%$14.93$13.2867,244 shs$62.07 million03/14/2024$13.30$12.82-3.61%$13.89$12.8039,899 shs$58.09 million03/13/2024$13.68$13.30-2.76%$14.14$13.3035,601 shs$60.26 million03/12/2024$13.22$13.68+3.46%$13.96$13.2019,664 shs$61.98 million03/11/2024$13.82$13.22-4.34%$13.80$13.0226,732 shs$59.90 million03/08/2024$13.66$13.82+1.17%$14.18$13.7813,125 shs$62.62 millionBiden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report03/07/2024$13.99$13.66-2.33%$13.97$13.604,766 shs$61.89 million03/06/2024$14.00$13.99-0.09%$14.20$13.6211,070 shs$63.24 million03/05/2024$14.14$14.00-1.00%$14.00$13.4018,252 shs$63.29 million03/04/2024$14.24$14.14-0.73%$14.58$13.6018,450 shs$63.93 million03/01/2024$14.15$14.24+0.66%$14.71$14.0811,909 shs$64.40 million02/29/2024$14.40$14.15-1.76%$14.71$14.0023,231 shs$63.98 million02/28/2024$14.57$14.40-1.17%$14.88$14.2412,990 shs$65.13 million02/27/2024$14.39$14.57+1.31%$15.00$14.0021,078 shs$65.90 million02/26/2024$14.00$14.39+2.76%$14.60$13.4021,823 shs$65.05 million02/23/2024$13.82$14.00+1.30%$14.00$13.6223,434 shs$63.30 million02/22/2024$13.80$13.82+0.14%$14.49$13.7010,998 shs$62.49 million02/21/2024$14.18$13.80-2.68%$14.00$13.6216,440 shs$62.40 million02/20/2024$14.30$14.18-0.83%$14.39$13.8016,429 shs$64.12 million02/19/2024$14.30$14.30$14.48$13.6023,455 shs$64.65 million02/16/2024$13.85$14.30+3.26%$14.38$13.6023,379 shs$64.65 million02/15/2024$13.58$13.85+1.96%$14.19$13.1622,608 shs$62.61 million02/14/2024$13.60$13.58-0.16%$14.00$13.3813,499 shs$61.40 million02/13/2024$14.10$13.60-3.53%$14.60$13.4013,302 shs$61.50 million02/12/2024$14.56$14.10-3.16%$15.20$13.9824,507 shs$63.75 million02/09/2024$13.42$14.56+8.49%$14.56$13.5643,637 shs$65.83 million02/08/2024$13.10$13.42+2.41%$13.60$12.9021,664 shs$60.68 million02/07/2024$13.42$13.10-2.37%$13.60$13.1011,874 shs$59.25 million02/06/2024$13.40$13.42+0.18%$13.98$13.2014,020 shs$60.69 million02/05/2024$13.98$13.40-4.16%$14.00$13.0517,366 shs$60.58 million02/02/2024$13.08$13.98+6.88%$13.98$12.8031,351 shs$63.21 million02/01/2024$12.82$13.08+2.00%$13.20$12.5030,917 shs$59.14 million Related Companies: Quince Therapeutics Stock Chart Dyadic International Stock Chart NKGen Biotech Stock Chart SAB Biotherapeutics Stock Chart OKYO Pharma Stock Chart AVROBIO Stock Chart Estrella Immunopharma Stock Chart Brainstorm Cell Therapeutics Stock Chart LENZ Therapeutics Stock Chart Cyclo Therapeutics Stock Chart Receive CDTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CDTX) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersThe AI stock to buy right nowStockEarningsThe A.I. story nobody is telling you (Read ASAP)TradeSmithCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryDid You Get Your Free Bitcoin Yet?Crypto Swap Profits$5,000 Gold?Stansberry ResearchREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cidara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.